Dose-dense therapy with non-pegylated liposomal doxorubicin (R-comp 14 vs. 21) is feasible and effective for elderly patients with newly diagnosed aggresive B-cell non-Hodgkin lymphoma

Autor:	Visani, G., Merli, F., Angrilli, F., Ferrara, F., Ilariucci, F., Falorio, S., Fioritoni, G., Alesiani, F., Brunori, M., Pollio, F., Celentano, M., Cangini, D., Ronconi, S., Catarini, M., Giglio, G., Vallisa, D., Arcari, A., Bernardi, D., Paolini, R., Guiducci, B., Barulli, S., Lucesole, M., Rocchi, MARCO BRUNO LUIGI, Loscocco, F., D'Adamo, F., Isidori, A.
Jazyk:	angličtina
Rok vydání:	2010
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______3656::94ec433951766d15c037262079cf7bb5 https://hdl.handle.net/11576/2530399 Zobrazit plný text záznamu